Detection at Public Facilities of 131I in Patients Treated for Differentiated Thyroid Cancer: Frequency, Sites, Management by Security Agents, and Physician Documentation Recommended for Patients

Athanasios Bikas; Di Wu; Evelyn Bethancourt; Michael Orquiza; Gary Bloom; Kenneth D. Burman; Leonard Wartofsky; Douglas Van Nostrand

doi:10.2967/jnumed.118.213256

Research ArticleTheranostics

Detection at Public Facilities of ¹³¹I in Patients Treated for Differentiated Thyroid Cancer: Frequency, Sites, Management by Security Agents, and Physician Documentation Recommended for Patients

Athanasios Bikas, Di Wu, Evelyn Bethancourt, Michael Orquiza, Gary Bloom, Kenneth D. Burman, Leonard Wartofsky and Douglas Van Nostrand

Journal of Nuclear Medicine May 2019, 60 (5) 638-643; DOI: https://doi.org/10.2967/jnumed.118.213256

Athanasios Bikas

1Department of Internal Medicine, MedStar Georgetown University Hospital, Washington, District of Columbia

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Di Wu

2MedStar Clinical Research Center, MedStar Health Research Institute, Hyattsville, Maryland

3Nuclear Medicine Research, MedStar Washington Hospital Center, Washington, District of Columbia

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Evelyn Bethancourt

4Division of Nuclear Medicine, MedStar Washington Hospital Center, Washington, District of Columbia

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael Orquiza

4Division of Nuclear Medicine, MedStar Washington Hospital Center, Washington, District of Columbia

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gary Bloom

5Thyroid Cancer Survivors’ Association, Inc., New York, New York; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kenneth D. Burman

6Division of Endocrinology, MedStar Washington Hospital Center, Washington, District of Columbia

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Leonard Wartofsky

2MedStar Clinical Research Center, MedStar Health Research Institute, Hyattsville, Maryland

6Division of Endocrinology, MedStar Washington Hospital Center, Washington, District of Columbia

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Douglas Van Nostrand

2MedStar Clinical Research Center, MedStar Health Research Institute, Hyattsville, Maryland

4Division of Nuclear Medicine, MedStar Washington Hospital Center, Washington, District of Columbia

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 60, Issue 5

May 1, 2019

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Detection at Public Facilities of 131I in Patients Treated for Differentiated Thyroid Cancer: Frequency, Sites, Management by Security Agents, and Physician Documentation Recommended for Patients

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Detection at Public Facilities of ¹³¹I in Patients Treated for Differentiated Thyroid Cancer: Frequency, Sites, Management by Security Agents, and Physician Documentation Recommended for Patients

Athanasios Bikas, Di Wu, Evelyn Bethancourt, Michael Orquiza, Gary Bloom, Kenneth D. Burman, Leonard Wartofsky, Douglas Van Nostrand

Journal of Nuclear Medicine May 2019, 60 (5) 638-643; DOI: 10.2967/jnumed.118.213256

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Detection at Public Facilities of ¹³¹I in Patients Treated for Differentiated Thyroid Cancer: Frequency, Sites, Management by Security Agents, and Physician Documentation Recommended for Patients

Athanasios Bikas, Di Wu, Evelyn Bethancourt, Michael Orquiza, Gary Bloom, Kenneth D. Burman, Leonard Wartofsky, Douglas Van Nostrand

Journal of Nuclear Medicine May 2019, 60 (5) 638-643; DOI: 10.2967/jnumed.118.213256

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Theranostics

Evidence-Based Clinical Protocols to Monitor Efficacy of [¹⁷⁷Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
¹⁷⁷Lu-Labeled Anticlaudin 6 Monoclonal Antibody for Targeted Therapy in Esophageal Cancer
Terbium-161, a Promising New Theranostic Radionuclide

Show more Theranostics

Clinical

Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
Addition of ¹³¹I-MIBG to PRRT (⁹⁰Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
SUVs Are Adequate Measures of Lesional ¹⁸F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden

Show more Clinical

Keywords

131I therapy
differentiated thyroid cancer
Security checkpoint
Documentation

Main menu

User menu

Search

Detection at Public Facilities of ¹³¹I in Patients Treated for Differentiated Thyroid Cancer: Frequency, Sites, Management by Security Agents, and Physician Documentation Recommended for Patients

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Theranostics

Clinical

Similar Articles

Keywords